Analyst Ratings for Novavax (NVAX)
NVAX Rating Summary
NVAX Price Target Summary
- Highest: $25.00 (Jefferies)
- Lowest: $6.00 (JPMorgan)
- Average: $14.14
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$14.14 (+54.9%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 59%
Avg. $ Target:
$14.14 (+54.9%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 59%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/24/2025 | Cantor Fitzgerald » Updated 1/13/2026 |
Pete Stavropoulos | New Coverage | Overweight (N/A) |
18.00 (N/A) |
8.36 (9.13) |
9.21% | Details |
| 8/28/2025 | H.C. Wainwright » Updated 4/21/2026 |
Sean Lee | New Coverage | Buy (N/A) |
16.00 (N/A) |
7.58 (9.13) |
20.45% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
